» Articles » PMID: 28828712

Temporal Trends in Prevalence, Incidence, and Mortality for Rheumatoid Arthritis in Quebec, Canada: a Population-based Study

Overview
Journal Clin Rheumatol
Publisher Springer
Specialty Rheumatology
Date 2017 Aug 23
PMID 28828712
Citations 15
Authors
Affiliations
Soon will be listed here.
Abstract

Health administrative data are a potentially efficient resource to conduct population-based research and surveillance, including trends in incidence and mortality over time. Our objective was to explore time trends in incidence and mortality for rheumatoid arthritis (RA), as well as estimating period prevalence. Our RA case definition was based on one or more hospitalizations with a RA diagnosis code, or three or more RA physician-billing codes, over 2 years, with at least one RA billing code by a rheumatologist, orthopedic surgeon, or internist. To identify incident cases, a "run-in" period of 5 years (1996-2000) was used to exclude prevalent cases. Crude age and sex-specific incidence rates were calculated (using data from 2001 to 2015), and sex-specific incidence rates were also standardized to the 2001 age structure of the Quebec population. We linked the RA cohort (both prevalent and incident patients) to the vital statistics registry, and standardized mortality rate ratios were generated. Negative binomial regression was used to test for linear change in standardized incidence rates and mortality ratios. The linear trends in standardized incidence rates did not show significant change over the study period. Mortality in RA was significantly higher than the general population and this remained true throughout the study period. Our prevalence estimate suggested 0.8% of the Quebec population may be affected by RA. RA incidence appeared relatively stable, and mortality was substantially higher in RA versus the general population and remained so over the study period. This suggests the need to optimize long-term RA outcomes.

Citing Articles

Prevalence, comorbidities, and disease-related complications of rheumatoid arthritis in Colombia: a national cross-sectional study based on administrative claims data.

Maldonado-Canon K, Buitrago G, Quintana-Lopez G Adv Rheumatol. 2025; 65(1):6.

PMID: 39871326 DOI: 10.1186/s42358-025-00437-8.


Gabapentinoid use and the risk of fractures in patients with inflammatory arthritis: nested case-control study in the Clinical Practice Research Datalink Aurum.

Scott I, Daud N, Bailey J, Twohig H, Hider S, Mallen C BMC Med. 2024; 22(1):575.

PMID: 39663522 PMC: 11636031. DOI: 10.1186/s12916-024-03774-5.


Cardiovascular risk markers (computed tomography‑coronary artery calcium and carotid intima‑media thickness) in patients with rheumatoid arthritis and controls.

Fatima J, Shukla V, Siddiqi Z, Shamsi M, Mateen S, Jabbar A Med Int (Lond). 2024; 4(5):52.

PMID: 39070004 PMC: 11273241. DOI: 10.3892/mi.2024.176.


National burden of rheumatoid arthritis in Canada, 1990-2019: findings from the Global Burden of Disease Study 2019 - a GBD collaborator-led study.

Hassen N, Lacaille D, Xu A, Alandejani A, Sidi S, Mansourian M RMD Open. 2024; 10(1).

PMID: 38216285 PMC: 10806499. DOI: 10.1136/rmdopen-2023-003533.


Mortality estimates and excess mortality in rheumatoid arthritis.

Black R, Lester S, Tieu J, Sinnathurai P, Barrett C, Buchbinder R Rheumatology (Oxford). 2023; 62(11):3576-3583.

PMID: 36919770 PMC: 10629787. DOI: 10.1093/rheumatology/kead106.


References
1.
Widdifield J, Paterson J, Bernatsky S, Tu K, Tomlinson G, Kuriya B . The epidemiology of rheumatoid arthritis in Ontario, Canada. Arthritis Rheumatol. 2014; 66(4):786-93. DOI: 10.1002/art.38306. View

2.
Blais C, Jean S, Sirois C, Rochette L, Plante C, Larocque I . Quebec Integrated Chronic Disease Surveillance System (QICDSS), an innovative approach. Chronic Dis Inj Can. 2014; 34(4):226-35. View

3.
Haroon N, Aggarwal A, Lawrence A, Agarwal V, Misra R . Impact of rheumatoid arthritis on quality of life. Mod Rheumatol. 2007; 17(4):290-5. DOI: 10.1007/s10165-007-0604-9. View

4.
Pollard L, Choy E, Scott D . The consequences of rheumatoid arthritis: quality of life measures in the individual patient. Clin Exp Rheumatol. 2005; 23(5 Suppl 39):S43-52. View

5.
Bernatsky S, Lix L, Hanly J, Hudson M, Badley E, Peschken C . Surveillance of systemic autoimmune rheumatic diseases using administrative data. Rheumatol Int. 2010; 31(4):549-54. DOI: 10.1007/s00296-010-1591-2. View